Perrigo ($PRGO) received the tentative approval from the FDA for its generic version of Valeant Pharmaceuticals' acne treatment ACANYA (clindamycin phosphate and benzoyl peroxide) Gel. Tentative approval means that the company's marketing application meets the standards for approval, however, patent issues need to be resolved. The company responded that it has settled litigation with Valeant and Dow Pharmaceutical Services.
Medtronic plc ($MDT) reported the FDA approval for its next-generation spinal cord stimulator (SCS) for the management of certain types of chronic intractable pain, Intellis. The company also announced the commercial launch of the product in the US.